{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Amarin Corporation plc"},"Symbol":{"label":"Symbol","value":"AMRN"},"Address":{"label":"Address","value":"77 SIR JOHN ROGERSON'S QUAY,BLOCK C ICONIC OFFICES, THE GREENWAY, BLOCK C ARDILAUN COURT, DUBLIN, D02 VK60, Ireland"},"Phone":{"label":"Phone","value":"+353 16699020"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa."},"CompanyUrl":{"label":"Company Url","value":"https://amarincorp.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Aaron D. Berg","title":"President, Chief Executive Officer & Director"},{"name":"David Keenan","title":"EVP-Technical Operations & President-Europe"},{"name":"Derek Kalinowski","title":"SVP-Manufacturing Operations"},{"name":"Nabil A. Abadir","title":"Global Chief Medical Officer & Senior VP"},{"name":"Steven B. Ketchum","title":"Chief Scientific Officer, President-R&D, EVP"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}